Saratov JOURNAL of Medical and Scientific Research

Diagnostic criteria for optic nerve atrophy in patients with multiple sclerosis determined by next generation spectral optical coherence tomography


Purpose: identifcation of diagnostic criteria for optic nerve atrophy by spectral optical coherent tomography in patients with multiple sclerosis (MS). Material and Methods. 81 patients with optic nerve atrophy due to MS (37 men, 44 women, mean age 35.6±3.7 years) were examined using spectral optical coherent tomography (S-OCT). Results. We obtained reliable data suggesting on the asymmetry of S-OCT parameters in patients with multiple sclerosis and optic nerve atrophy. In the process of a detailed assessment of the thickness of the GCS+IPL complex, signifcant difer-ences in the worst and paired eyes were obtained. In addition, when the total aggregating all of the results obtained by the method of binary logical regression determined the threshold for partial atrophy of the optic nerve due to MS. The average thickness of GCS+IPL complex, as determined by S-OCT, is a reliable marker of neuroaxonal degeneration in patients with optic nerve atrophy due to MS. Conclusion. S-OCT criteria for optic nerve atrophy in multiple sclerosis are a decrease in the average thickness of the retinal nerve fber layer of less than 62 microns, combined with a decrease in the average thickness of retinal ganglion cell complex and the inner plexiform layer less than 52 microns, thickness of upper segment of GCS+IPL less than 51 μm, and the lower segment of GCS+IPL less than 50 microns.

1 Gusev EI, Zavalishin IA, Boiko AN. Multiple sclerosis: clinical guidelines. Moscow, 2011; 782 p.
2 Burkholder BM, Osborne B, Loguidice MJ, et al. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch Neurology 2009; 66 (1): 1366–72
3 Davydovskaya MV, Tsysar MA, Boyko AN, et al. Damage to the complex of ganglion cells and the nerve fberlayer of the retina in multiple sclerosis. Journal of Neurology and Psychiatry 2012; 2 (2): 47–51
4 Shpak AA. New nomenclature of optical coherence tomography. Ophthalmosurgery 2015; (3): 80–2
5 Maslova NN, Andreeva EA. Possibilities of neuroophthalmologic examination in the early diagnosis of multiple sclerosis. Medical Almanac 2013; 29 (5): 201–3
6 Akopyan VS, Boyko AN, Davydovskaya MV, et al. Neuroarchitecture of the retina in multiple sclerosis: diagnostic capabilities of optical coherence tomography (preliminary results). Ophthalmology 2011; (1): 32–36
7 Fu Y. New imaging techniques in the diagnosis of multiple sclerosis. Expert Opinion Medical Diagnostic 2008; 2 (9): 1055–65
8 Garcia-Martin E, Rodriguez-Mena D, Herrero R, et al. Neuro-ophthalmologic evaluation, quality of life, and functional disability in patients with MS. Neurology 2013; 81: 76–83
9 Gordon-Lipkin E, Chodklwski B, Reich DS, et al. Retinal nerve fber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007; 69: 1603–9
10 Graves J, Balcer LJ. Eye disorders in patients with multiple sclerosis: natural history and management. Clinical Ophthalmology 2010; 4: 1409–22
11 Grazioli E, Zivadinov R, Weinstock-Guttman B, et al. Retinal nerve fber layer thickness is associated with brain MRI outcomes in multiple sclerosis. Journal of the Neurological Sciences 2008; 268: 12–7
12 Green AJ, McQuaid S, Hauser SL, et al. Ocular pathology in multiple sclerosis: retinal atrophy and infammation irrespective of disease duration. Brain 2010; 133: 1591–601
13 Henderson APD, Altmann DR, Trip SA, et al. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials. Brain 2010; 133: 2592–602
14 Henderson APD, Trip SA, Schottman PG, et al. An investigation of the retinal nerve fbre layer in progressive multiple sclerosis using optical coherence tomography. Brain 2008; 131: 277–87
15 Oberwahrenbrock T, Ringelstein M, Jentschke S, et al. Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Multiple Sclerosis Journal 2013; 19: 1887–95
16 Ratchford JN, Saidha S, Sotirchos ES, et al. Active MS is associated with accelerated retinal ganglion cell / inner plexiform layer thinning. Neurology 2013; 80: 47–54
17 Коваленко A. B., Бойко Э. В., Одиннак М. М. и др. Диагностические возможности оптической когерентной томографии у больных рассеянным склерозом. Вестн. Рос. Воен.-мед. акад. 2009; 28 (4): 16–21
18 Иойлева Е. Э., Кривошеева М. С., Смирнова М. А. Результаты обследования пациентов с оптическим невритом в дебюте рассеянного склероза. Вестник Оренбурского государственного университета 2014; 12: 143–6
19 Иойлева Е. Э., Кривошеева М. С., Макаренко И. Р. Исследование асимметрии параметров диска зрительного нерва при рассеянном склерозе по данным ОКТ. Вестник Тамбовского университета. Серия: Естественные и технические науки 2016; 21 (4): 1559–63
20 Способ определения показаний к лечению частичной атрофии зрительного нерва при рассеянном склерозе: патент РФ №2625784 от 01.06.2016 / Е. Э. Иойлева, М. С. Кривошеева.

2019_02-1_486-489.pdf562.85 KB

No votes yet